Complications and Risk Factors of Pediatric Oncology Patients After Totally Implantable Access Ports Insertion

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300071125

Enrollment

Unknown

Registered

2023-05-05

Start date

2022-11-25

Completion date

Unknown

Last updated

2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Oncology

Interventions

Case series :None

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Children's tumor patients undergoing infusion port implantation surgery in children 2. Complete clinical and follow-up data

Exclusion criteria

Exclusion criteria: 1. Surgical failure 2. History of previous infusion port implantation surgery 3. Patients with immune system diseases or weakened immunity that may affect the analysis results

Design outcomes

Primary

Measure	Time frame
infection;thrombus;occlusion;port flipping;catheter rupture;	—

Countries

China

Contacts

Public ContactYingjun Zhang

Sun Yat-sen University Cancer Center

zhangyingj@sysucc.org.cn+86 15820284143

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026